If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.35    -0.25 (-2.36%)
Bid:
10.20
Ask:
10.50
Spread: 0.30 (2.941%)
Market Cap: £14.38m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

13 Jun 2024 13:06

RNS Number : 3635S
Ebiquity PLC
13 June 2024
 

 

Ebiquity Plc

("the Company")

 

13 June 2024

 

 

TVR

 

Following the exercise of options on 12 June 2024, over 45,000 ordinary shares which have been satisfied from the Ebiquity plc Employee Benefit Trust ("EBT"), the EBT now holds 3,879,703 issued Ordinary Shares to satisfy certain LTIP awards for the Company's senior management team. The trustee has agreed not to vote the Ordinary Shares held by it. As such 3,879,703 Ordinary Shares are treated as not carrying voting rights. The figure of 136,606,301 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

 

 

Enquiries: 

 

Ebiquity plc

+44 (0) 20 7650 9600

Lorraine Young, Company Secretary

 

 

 

Camarco

 

Ben Woodford

+44 (0) 7990 653 341

Geoffrey Pelham-Lane

+44 (0) 7733 124 226

 

 

Panmure Gordon (Financial Adviser, Nomad and Broker)

+44 (0) 20 7886 2500

Dominic Morley / Dougie McLeod (Corporate Advisory)

 

Mark Murphy / Sam Elder (Corporate Broking)

 

 

About Ebiquity plc

 

Ebiquity plc (LSE AIM: EBQ) is a world leader in media investment analysis. It harnesses the power of data to provide independent, fact-based advice, enabling brand owners to perfect media investment decisions and improve business outcomes. Ebiquity is able to provide independent, unbiased advice and solutions to brands because we have no commercial interest in any part of the media supply chain.

 

We are a data-driven solutions company helping brand owners drive efficiency and effectiveness from their media spend, eliminating wastage and creating value. We provide analysis and solutions through four Service Lines: Media Management, Media Performance, Marketing Effectiveness, and Contract compliance.

 

Ebiquity's clients are served by more than 600 media specialists operating from 18 offices covering 80% of the global advertising market.

 

The Company has the most comprehensive, independent view of today's global media market, analysing US$55bn of media spend from 75 markets annually, including trillions of digital media impressions. Our Contract compliance division, FirmDecisions, audits US$40bn of contract value annually.

 

As a result, more than 70 of the world's top 100 advertisers today choose Ebiquity as a trusted independent media advisor.

 

For further information, please visit: www.ebiquity.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUORURSNUNAAR
Date   Source Headline
8th Sep 20083:00 pmRNSResult of AGM
8th Sep 20087:00 amRNSAGM Statement
29th Aug 200810:23 amRNSTotal Voting Rights
7th Aug 20081:33 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSChange of Name to Ebiquity
28th Jul 20082:05 pmRNSHolding(s) in Company
23rd Jul 20087:00 amRNSFinal Results
11th Jun 20084:00 pmRNSHolding(s) in Company
3rd Jun 20087:00 amRNSTrading Statement
7th May 20084:10 pmRNSHolding(s) in Company
25th Apr 20087:00 amRNSStrategy update
24th Apr 20087:01 amRNSBoard appointment
3rd Apr 20088:41 amRNSDirector/PDMR Shareholding
12th Mar 200810:32 amRNSHolding(s) in Company
29th Feb 200812:15 pmRNSHolding(s) in Company
22nd Feb 20081:11 pmRNSDirectorate Change
6th Feb 20083:47 pmRNSHolding(s) in Company
4th Feb 20082:07 pmRNSHolding(s) in Company
4th Feb 20082:05 pmRNSHolding(s) in Company
24th Jan 20087:01 amRNSDirector/PDMR Shareholding
23rd Jan 20087:02 amRNSInterim Results
10th Jan 200810:11 amRNSNotice of Results
7th Dec 20073:39 pmRNSHolding(s) in Company
7th Dec 20079:17 amRNSHolding(s) in Company
8th Nov 20071:14 pmRNSHolding(s) in Company
31st Oct 20072:59 pmRNSTotal Voting Rights
29th Oct 20073:07 pmRNSAdditional Listing
29th Oct 20078:56 amRNSAdditional Listing
11th Oct 200712:35 pmRNSDirector/PDMR Shareholding
2nd Oct 20074:27 pmRNSDirector/PDMR Shareholding
28th Sep 20073:51 pmRNSTotal Voting Rights
27th Sep 20077:01 amRNSBoard Changes
21st Sep 200711:31 amRNSAdditional Listing
14th Sep 20072:42 pmRNSHolding in US Operation
6th Sep 200710:36 amRNSAGM Statement
15th Aug 20074:39 pmRNSAIM Rule 26
15th Aug 20078:00 amRNSChange of Adviser
24th Jul 20077:00 amRNSFinal Results
16th Jul 20072:41 pmRNSNotice of Results
10th Jul 20074:02 pmRNSNotice of Results
4th May 20077:01 amRNSDirector Shareholding
3rd May 200711:44 amRNSMarketing Spend Q1 07
3rd May 20079:58 amRNSHolding(s) in Company
2nd May 200711:55 amRNSGrant of Share Options
30th Apr 20077:03 amRNSSecond Interim Results
18th Apr 20077:01 amRNSBoard Appointment
10th Apr 20073:44 pmRNSNotice of Results
21st Mar 20073:01 pmRNSHolding(s) in Company
21st Mar 20072:57 pmRNSHolding(s) in Company
21st Mar 20072:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.